Search by Drug Name or NDC

    NDC 67877-0509-05 Ezetimibe and Simvastatin 10; 40 mg/1; mg/1 Details

    Ezetimibe and Simvastatin 10; 40 mg/1; mg/1

    Ezetimibe and Simvastatin is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ascend Laboratories, LLC. The primary component is EZETIMIBE; SIMVASTATIN.

    Product Information

    NDC 67877-0509
    Product ID 67877-509_28cf8a44-6766-4ffa-9909-4d848245e921
    Associated GPIs 39994002300340
    GCN Sequence Number 057865
    GCN Sequence Number Description ezetimibe/simvastatin TABLET 10 MG-40MG ORAL
    HIC3 M4M
    HIC3 Description ANTIHYPERLIP.HMG COA REDUCT INHIB-CHOLEST.AB.INHIB
    GCN 23127
    HICL Sequence Number 026505
    HICL Sequence Number Description EZETIMIBE/SIMVASTATIN
    Brand/Generic Generic
    Proprietary Name Ezetimibe and Simvastatin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ezetimibe and Simvastatin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 10; 40
    Active Ingredient Units mg/1; mg/1
    Substance Name EZETIMIBE; SIMVASTATIN
    Labeler Name Ascend Laboratories, LLC
    Pharmaceutical Class Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209222
    Listing Certified Through 2024-12-31

    Package

    NDC 67877-0509-05 (67877050905)

    NDC Package Code 67877-509-05
    Billing NDC 67877050905
    Package 500 TABLET in 1 BOTTLE (67877-509-05)
    Marketing Start Date 2017-12-24
    NDC Exclude Flag N
    Pricing Information N/A